May 2026 Webinar

Type 2 Inflammation Across Diseases: Eosinophils, IL-5 Cytokine, and Unmet Needs

Wednesday, 6 May 2026

11:00 am - 12:30 pm US Eastern / 5:00 pm - 6:30 pm Central Europe

Register Here

Sponsored by:

Our live webinars are completely free of charge, we just ask that you register in advance. Webinars are hosted on Zoom and audience members can ask questions using the Q&A feature. Real-time closed captioning is available for those with hearing impairments.

Program

11:00 am – 11:10 am: Introduction and Welcome
Moderators: David Jacoby - United States & Nicolas Hogan - United States

11:10 am – 11:28 am: Type 2 Inflammation Across Diseases (Severe Asthma, COPD, Nasal Polyps, EGPA)
Diego Maselli - United States

11:28 am – 11:34 am: Audience Q&A

11:35 am – 11:53 am: Unmet Patient Needs in Severe Asthma: From OCS Dependence to Delayed Biologic Use
Sameer Mathur - United States

11:53 am – 11:59 am: Audience Q&A

12:00 pm – 12:18 pm: Eosinophils in the IL-5 Era: Mechanisms, Biomarkers, and Clinical Impact
Manali Mukherjee - Canada

12:18 pm – 12:24 pm: Audience Q&A

12:25 pm – 12:30 pm: Closing Remarks & Concluding Discussion

Speakers & Moderators

Diego J. Maselli, MD, FCCP

Diego J. Maselli, MD, FCCP, is the Division Chief of Pulmonary Diseases and Critical Care Medicine and a Professor of Medicine at University of Texas Health at San Antonio. He earned his medical degree from Universidad Francisco Marroquín in Guatemala and completed his internal medicine residency at The University of Texas Medical School in Houston, followed by fellowships in pulmonary diseases and critical care medicine at UT Health San Antonio. In 2016, he founded UT Health’s Severe Asthma Program.

Dr. Maselli has published more than 90 peer-reviewed articles, with a focus on severe asthma, noncystic fibrosis bronchiectasis, and COPD. He is also a frequent speaker at national and international scientific meetings. Dr. Maselli has received multiple honors for excellence in education, research, and patient care, including repeated Distinguished CHEST Educator awards. He is Chair of the Asthma and COPD Section within the Airways Disorders Network and a former Section Editor of CHEST Physician.

Sameer Mathur, MD, PhD

Dr. Mathur is a physician-scientist and a practicing Allergist/Immunologist at the University of Wisconsin – Madison. He completed a combined MD/PhD at Northwestern University followed by Internal Medicine Residency at Loyola University. He did his Post-Doctoral training at the University of Illinois-Chicago with Dr. Steve Ackerman and Fellowship training in Allergy and Immunology at the University of Wisconsin – Madison with Drs. William Busse and Nizar Jarjour. His research interest is understanding how eosinophils contribute to disease activity in eosinophilic disorders, including asthma and eosinophilic esophagitis. He also leads clinic-based projects to improve the care for patients with mast cell disorders, including urticaria, angioedema, and mast cell activation syndrome.

Manali Mukherjee, MSc, PhD

Dr. Mukherjee is an Assistant Professor in the Division of Respirology, Department of Medicine, and a translational scientist affiliated with the Research Institute of St. Joe's, Hamilton. Her expertise lies in the arena of developing/validating airway biomarkers, mechanisms of airway inflammation, and response to biologic therapies. She has identified the presence of localized autoimmune responses in the airways of patients with complex airways disease, and determined their pathogenic role in driving disease severity, particularly in asthma, and eosinophilic granulomatosis with polyangiitis (a systemic autoimmune disease with pulmonary complications).Dr. Mukherjee’s research program thus focusses on “Lung autoimmunity and biomarkers”. She is the current recipient of the Emerging Researcher Award in Allergic Asthma awarded conjointly by the Canadian Institutes of Health Research (CIHR) and the Canadian Asthma, Allergy and Immunology Foundation (CAAIF). Her lab is funded by federal and non-federal sources including CIHR-ICRH and industry.

David B. Jacoby M.D. | OHSU People | OHSU

David Jacoby, MD

Dr. David Jacoby is a professor in the Department of Medicine, Division of Pulmonary and Critical Care Medicine. His secondary appointment is professor in the Department of Chemical Physiology and Biochemistry, OHSU School of Medicine.

He was born in New York, and is a graduate of Princeton University and New York Medical College. He was a resident and chief resident in internal medicine at Temple University Hospital and did his fellowship at the Cardiovascular Research Institute at the University of California, San Francisco.

He was a member of the Division of Pulmonary and Critical Care Medicine at Johns Hopkins for 13 years, where he was research director for the division. As part of the Oregon Opportunity Act, Dr. Jacoby was recruited to OHSU as chief of pulmonary and critical care in 2003. He led the expansion of that division in patient care, research and education. He became interim chair of the Department of Medicine in 2017 and permanent chair in 2018. He was named interim dean of the School of Medicine in 2021 and dean in 2022. He stepped down as dean in 2024, returning to his tenured faculty role.

   

Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

OK